Heterogeneity of mprF sequences in methicillin-resistant Staphylococcus aureus clinical isolates: role in cross-resistance between daptomycin and host defense antimicrobial peptides.
about
Induced Bacterial Cross-Resistance toward Host Antimicrobial Peptides: A Worrying PhenomenonMechanisms of drug resistance: daptomycin resistanceAntimicrobial Activity of Cationic Antimicrobial Peptides against Gram-Positives: Current Progress Made in Understanding the Mode of Action and the Response of Bacteriaβ-Lactams enhance daptomycin activity against vancomycin-resistant Enterococcus faecalis and Enterococcus faecium in in vitro pharmacokinetic/pharmacodynamic models.Heterogeneity of genetic pathways toward daptomycin nonsusceptibility in Staphylococcus aureus determined by adjunctive antibioticsFrequency and Distribution of Single-Nucleotide Polymorphisms within mprF in Methicillin-Resistant Staphylococcus aureus Clinical Isolates and Their Role in Cross-Resistance to Daptomycin and Host Defense Antimicrobial PeptidesMechanisms of resistance to antimicrobial peptides in staphylococci.Stepwise decrease in daptomycin susceptibility in clinical Staphylococcus aureus isolates associated with an initial mutation in rpoB and a compensatory inactivation of the clpX gene.Large tandem chromosome expansions facilitate niche adaptation during persistent infection with drug-resistant Staphylococcus aureusPhenotypic and genotypic correlates of daptomycin-resistant methicillin-susceptible Staphylococcus aureus clinical isolates.Impact of exposure of methicillin-resistant Staphylococcus aureus to polyhexanide in vitro and in vivo.Into the storm: Chasing the opportunistic pathogen Staphylococcus aureus from skin colonisation to life-threatening infections.Down-regulation of the two-component system and cell-wall biosynthesis-related genes was associated with the reversion to daptomycin susceptibility in daptomycin non-susceptible methicillin-resistant Staphylococcus aureus.Dysregulation of mprF and dltABCD expression among daptomycin-non-susceptible MRSA clinical isolates.Characterization of the Mechanisms of Daptomycin Resistance among Gram-Positive Bacterial Pathogens by Multidimensional Lipidomics.Characterization of genetic changes associated with daptomycin nonsusceptibility in Staphylococcus aureus.Mechanism of High-Level Daptomycin Resistance inDaptomycin Resistant Clinical Strain With Novel Non-synonymous Mutations in the and Genes: A New Insight Into Daptomycin Resistance
P2860
Q26752291-3B9D14AE-9077-48F4-B3C3-718143C44E07Q26779944-52F777CE-8CE8-4A00-B15E-5FD896E3E310Q28072687-C3A145D7-BDD2-4B8C-9CEB-C718EE3BC951Q35385108-75DA0439-3080-418B-89F4-82BDE09BD396Q35385568-FB25F57F-86B2-4C4A-8BE9-B3E49716F097Q35860154-12BA0161-6F0F-4608-B501-886832A2B358Q35963449-56F30004-E66A-469C-82EA-4C805837E10FQ36158472-8A2DCE68-5D3C-49A7-B628-72A9CC7D73C8Q37658042-60EF7455-856C-4277-AD65-14F401558953Q39000860-99BCC48D-0FD5-45C2-AA8F-05ACAC189B19Q40103251-F2AB5239-B38A-40A8-B649-C4FDF9692A5CQ40165712-1E723BA1-40D4-4656-8BA1-49673AD1F574Q40224178-3189DE47-3B26-4463-AEF9-D312A35108E9Q40696439-53868F2A-2669-4B61-B8F9-44981F34696BQ46240694-011294E4-3EFB-40F7-BECA-EE20A7D9B67BQ55234569-6F89D725-3E68-474B-8061-107CE50C72ECQ58795935-9AAE973C-681B-46A4-AC4C-3C38B56F777FQ59136449-7045FC92-6B51-47E2-835B-D2C846FD69E8
P2860
Heterogeneity of mprF sequences in methicillin-resistant Staphylococcus aureus clinical isolates: role in cross-resistance between daptomycin and host defense antimicrobial peptides.
description
2014 nî lūn-bûn
@nan
2014 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Heterogeneity of mprF sequence ...... efense antimicrobial peptides.
@ast
Heterogeneity of mprF sequence ...... efense antimicrobial peptides.
@en
Heterogeneity of mprF sequence ...... efense antimicrobial peptides.
@nl
type
label
Heterogeneity of mprF sequence ...... efense antimicrobial peptides.
@ast
Heterogeneity of mprF sequence ...... efense antimicrobial peptides.
@en
Heterogeneity of mprF sequence ...... efense antimicrobial peptides.
@nl
prefLabel
Heterogeneity of mprF sequence ...... efense antimicrobial peptides.
@ast
Heterogeneity of mprF sequence ...... efense antimicrobial peptides.
@en
Heterogeneity of mprF sequence ...... efense antimicrobial peptides.
@nl
P2093
P2860
P356
P1476
Heterogeneity of mprF sequence ...... efense antimicrobial peptides.
@en
P2093
Arnold S Bayer
Cynthia C Nast
George Sakoulas
Joseph Pogliano
Kuan-Tsen Chen
Michael R Yeaman
Nagendra N Mishra
Poochit Nonejuie
Soo-Jin Yang
Steven N Ellison
P2860
P304
P356
10.1128/AAC.03422-14
P407
P577
2014-10-06T00:00:00Z